ArticleRadiation oncology (London, England)2024

ALA-RDT in GBM: protocol of the phase I/II dose escalation trial of radiodynamic therapy with 5-Aminolevulinic acid in patients with recurrent glioblastoma.

Niklas Benedikt Pepper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.